These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 12093142)

  • 1. A case of Parkinsonism due to lithium intoxication: treatment with Pramipexole.
    Dallocchio C; Mazzarello P
    J Clin Neurosci; 2002 May; 9(3):310-1. PubMed ID: 12093142
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pramipexole in Parkinson's disease. A short-term study using the combined levodopa-dopamine agonist test.
    Fabbrini G; Barbanti P; Aurilia C; Pauletti C; Meco G
    Funct Neurol; 2002; 17(4):199-201. PubMed ID: 12675263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dopamine agonists in early therapy for Parkinson disease: promise and problems.
    Tanner CM
    JAMA; 2000 Oct; 284(15):1971-3. PubMed ID: 11035895
    [No Abstract]   [Full Text] [Related]  

  • 4. Pramipexole ameliorates neurologic and psychiatric symptoms in a Westphal variant of Huntington's disease.
    Bonelli RM; Niederwieser G; Diez J; Gruber A; Költringer P
    Clin Neuropharmacol; 2002; 25(1):58-60. PubMed ID: 11852299
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pramipexole vs levodopa as initial treatment for Parkinson disease: A randomized controlled trial. Parkinson Study Group.
    Parkinson Study Group
    JAMA; 2000 Oct; 284(15):1931-8. PubMed ID: 11035889
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pramipexole. A review of its use in the management of early and advanced Parkinson's disease.
    Dooley M; Markham A
    Drugs Aging; 1998 Jun; 12(6):495-514. PubMed ID: 9638397
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and efficacy of pramipexole in early Parkinson disease. A randomized dose-ranging study. Parkinson Study Group.
    JAMA; 1997 Jul; 278(2):125-30. PubMed ID: 9214527
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ropinirole and pramipexole, the new agonists.
    Hobson DE; Pourcher E; Martin WR
    Can J Neurol Sci; 1999 Aug; 26 Suppl 2():S27-33. PubMed ID: 10451757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pramipexole, ropinirole, and mania in Parkinson's disease.
    Singh A; Althoff R; Martineau RJ; Jacobson J
    Am J Psychiatry; 2005 Apr; 162(4):814-5. PubMed ID: 15800169
    [No Abstract]   [Full Text] [Related]  

  • 10. Current advances in Parkinson's disease.
    Ball J
    Trends Neurosci; 2001 Jul; 24(7):367-9. PubMed ID: 11467283
    [No Abstract]   [Full Text] [Related]  

  • 11. The initial drug treatment of older patients with Parkinson's disease - consider an agonist, but don't demonise dopa.
    MacMahon DG
    Age Ageing; 2003 May; 32(3):244-5. PubMed ID: 12720606
    [No Abstract]   [Full Text] [Related]  

  • 12. Modafinil and pramipexole-associated somnolence.
    Montastruc JL; Rascol O
    Mov Disord; 2001 Jul; 16(4):783-4. PubMed ID: 11481716
    [No Abstract]   [Full Text] [Related]  

  • 13. Treatment effects on nigrostriatal projection integrity in partial 6-OHDA lesions: comparison of L-DOPA and pramipexole.
    Kemmerer ES; Desmond TJ; Albin RL; Kilbourn MR; Frey KA
    Exp Neurol; 2003 Sep; 183(1):81-6. PubMed ID: 12957491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pramipexole, a nonergot dopamine agonist, is effective against rest tremor in intermediate to advanced Parkinson's disease.
    Künig G; Pogarell O; Möller JC; Delf M; Oertel WH
    Clin Neuropharmacol; 1999; 22(5):301-5. PubMed ID: 10516884
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pramipexole--a new dopamine agonist for the treatment of Parkinson's disease.
    Bennett JP; Piercey MF
    J Neurol Sci; 1999 Feb; 163(1):25-31. PubMed ID: 10223406
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New drugs for the treatment of Parkinson's disease.
    LeWitt PA
    Pharmacotherapy; 2000 Jan; 20(1 Pt 2):26S-32S. PubMed ID: 10641989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alopecia induced by dopamine agonists.
    Tabamo RE; Di Rocco A
    Neurology; 2002 Mar; 58(5):829-30. PubMed ID: 11889256
    [No Abstract]   [Full Text] [Related]  

  • 18. [Pramipexole in Parkinson disease. Results of a treatment observation].
    Reichmann H; Brecht HM; Kraus PH; Lemke MR
    Nervenarzt; 2002 Aug; 73(8):745-50. PubMed ID: 12242961
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of pramipexole, a novel dopamine (DA) agonist, in advanced Parkinson's disease.
    Molho ES; Factor SA; Weiner WJ; Sanchez-Ramos JR; Singer C; Shulman L; Brown D; Sheldon C
    J Neural Transm Suppl; 1995; 45():225-30. PubMed ID: 8748629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dramatic Response to Pramipexole in Delayed-Onset Parkinsonism from Osmotic Demyelinating Syndrome.
    Han SC; Katus L; Frucht S
    Tremor Other Hyperkinet Mov (N Y); 2020 Jun; 10():9. PubMed ID: 32775023
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.